Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004518778 | SCV005036109 | pathogenic | Hereditary cancer-predisposing syndrome | 2023-11-14 | criteria provided, single submitter | clinical testing | The c.769delC pathogenic mutation, located in coding exon 6 of the TP53 gene, results from a deletion of one nucleotide at nucleotide position 769, causing a translational frameshift with a predicted alternate stop codon (p.L257Wfs*88). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |